SLC6A3 and Lewy body dementia: A retrospective analysis assessing the impact of dopamine transporter imaging on patients with suspected DLB during their diagnostic workup showed significant impact on diagnosis and subsequent management, as 90% of patient with an abnormal DaTscan had a postscan clinical diagnosis of DLB, and 95% of patients with normal imaging had an alternative clinical diagnosis [50].